EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

NKp30 : A Key Membrane Molecule in the Fight Against Cancer and Infection

Yushu Shao, Yang Zhang, Jiaying Cao, Junyu He, Qian He, Yan Lei, Ning Tang, Yanhong Zhou iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202501490r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, 2025. Verfasst von Yushu Shao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changs…. Hauptthemen laut MEDLINE: Neoplasms, Natural Cytotoxicity Triggering Receptor 3, Killer Cells, Natural, Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HSTD | Natural Science Foundation of Hunan Province (), Health Commission of Hunan Province (), Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer cells (NK) are crucial components of the immune system. NKp30, a significant activation receptor on the NK cell membrane, plays a cytotoxic role by recognizing and binding to corresponding ligands. This interaction mediates the activation of NK cells and the release of regulatory factors, participating in antitumor and anti‐infection processes. This review systematically summarizes the structural features and basic functions of NKp30, the impact of N‐terminal glycosylation on NKp30 function, related NKp30 ligands and their roles, as well as the antitumor and anti‐infective functions and mechanisms of NKp30. The aim is to provide a new perspective for a comprehensive understanding of NKp30 function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNatural Cytotoxicity Triggering Receptor 3Killer Cells, NaturalInfectionsHumansAnimals

Stichwörter der Autor:innen

NKp30antitumoranti‐infectionmechanismsnatural killer cell

Substanzen

Natural Cytotoxicity Triggering Receptor 3NCR3 protein, human

Autor:innen und Institutionen

  • Department of Blood Transfusion, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
  • Cancer Research Institute, Basic School of Medicine, Central South University, Changsha, Hunan, China.
  • Department of Clinical Laboratory, Brain Hospital of Hunan Province (The Second People's Hospital of Hunan Province), Changsha, Hunan, People's Republic of China.
  • Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
  • Office of Scientific Research Administration, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.

ORCID-Profile: Yanhong Zhou

Förderung

  • HSTD | Natural Science Foundation of Hunan Province ()
  • Health Commission of Hunan Province ()
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Shao, Y., Zhang, Y., Cao, J., He, J., He, Q., Lei, Y., Tang, N., & Zhou, Y. (2025). NKp30 : A Key Membrane Molecule in the Fight Against Cancer and Infection. The FASEB Journal. https://doi.org/10.1096/fj.202501490r

Vancouver

Shao Y, Zhang Y, Cao J, He J, He Q, Lei Y, et al. NKp30 : A Key Membrane Molecule in the Fight Against Cancer and Infection. The FASEB Journal. 2025. doi:10.1096/fj.202501490r

BibTeX
@article{Shao2025,
  author = {Shao, Yushu and Zhang, Yang and Cao, Jiaying and He, Junyu and He, Qian and Lei, Yan and Tang, Ning and Zhou, Yanhong},
  title = {NKp30 : A Key Membrane Molecule in the Fight Against Cancer and Infection},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501490r}
}
Kostenlos starten →